Abstract
LBA13 Dostarlimab + chemotherapy (CT) vs pembrolizumab + CT in metastatic non-squamous non-small cell lung cancer (NSCLC): Updated Asian subgroup analyses of the PERLA trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have